The Endothelial Glycocalyx as a Key Mediator of Albumin Handling and the Development of Diabetic Nephropathy

被引:13
|
作者
Korakas, Emmanouil [1 ]
Ikonomidis, Ignatios [2 ]
Markakis, Konstantinos [1 ]
Raptis, Athanasios [1 ]
Dimitriadis, George [1 ]
Lambadiari, Vaia [1 ]
机构
[1] Natl & Kapodistrian Univ Athens, Attikon Univ Hosp, Med Sch, Dept Internal Med 2, Athens, Greece
[2] Natl & Kapodistrian Univ Athens, Attikon Univ Hosp, Med Sch, Cardiol Dept 2, Athens, Greece
关键词
Glycocalyx; vascular permeability; imaging; albuminuria; nephropathy; oxidative stress; diabetes; HEPARAN-SULFATE PROTEOGLYCAN; SURFACE-LAYER; GLOMERULAR-FILTRATION; CELL GLYCOCALYX; IN-VIVO; STRUCTURAL DETERMINANTS; EXTRACELLULAR-MATRIX; INDUCED DEGRADATION; CHARGE SELECTIVITY; VEGF-A;
D O I
10.2174/1570161118666191224120242
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The endothelial glycocalyx is a complex mesh of proteoglycans, glycoproteins and other soluble components, which cover the vascular endothelium. It plays an important role in many physiological processes including vascular permeability, transduction of shear stress and interaction of blood cells and other molecules with the vascular wall. Its complex structure makes its precise assessment challenging, and many different visualization techniques have been used with varying results. Diabetes, one of the main disease models where disorders of the glycocalyx are present, causes degradation of the glycocalyx through a variety of molecular pathways and especially through oxidative stress due to the action of reactive oxygen species. As the glycocalyx has been primarily studied in the glomerular endothelium, more evidence points towards a vital role in albumin handling and, consequently, in diabetic nephropathy. Therefore, the maintenance or restoration of the integrity of the glycocalyx seems a promising therapeutic target. In this review, we consider the structural and functional capacities of the endothelial glycocalyx, the available methods for its evaluation, the mechanisms through which diabetes leads to glycocalyx degradation and albuminuria, and possible treatment options targeting the glycocalyx.
引用
收藏
页码:619 / 631
页数:13
相关论文
共 50 条
  • [41] Endothelial cell-selective adhesion molecule regulates albuminuria in diabetic nephropathy
    Hara, Tetsuya
    Ishida, Tatsuro
    Cangara, Husni M.
    Hirata, Ken-ichi
    MICROVASCULAR RESEARCH, 2009, 77 (03) : 348 - 355
  • [42] Mapping Txnip: Key connexions in progression of diabetic nephropathy
    Kumar, Anil
    Mittal, Ruchika
    PHARMACOLOGICAL REPORTS, 2018, 70 (03) : 614 - 622
  • [43] Mechanistic Pathogenesis of Endothelial Dysfunction in Diabetic Nephropathy and Retinopathy
    Yang, Jing
    Liu, Zhangsuo
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [44] Urinary albumin as an indicator of diabetic nephropathy lesions in Japanese type 2 diabetic patients
    Moriya, T
    Moriya, R
    Yajima, Y
    Steffes, MW
    Mauer, M
    NEPHRON, 2002, 91 (02): : 292 - 299
  • [45] A novel mechanism of action for salidroside to alleviate diabetic albuminuria: effects on albumin transcytosis across glomerular endothelial cells
    Wu, Dan
    Yang, Xiaoyan
    Zheng, Tao
    Xing, Shasha
    Wang, Jianghong
    Chi, Jiangyang
    Bian, Fang
    Li, Wenjing
    Xu, Gao
    Bai, Xiangli
    Wu, Guangjie
    Jin, Si
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2016, 310 (03): : E225 - E237
  • [46] Development of diabetic nephropathy in nude mice
    Lin, S.
    Xu, P-C.
    Huang, Q-E.
    Jia, J-Y.
    Jia, Z-H.
    Wei, L.
    Zheng, Z-F.
    Shang, W-Y.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2013, 36 (11) : 938 - 943
  • [47] Agents in development for the treatment of diabetic nephropathy
    Fukami, K
    Cooper, ME
    Forbes, JM
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2005, 14 (03) : 279 - 294
  • [48] Development of diabetic nephropathy in nude mice
    S. Lin
    P.-C. Xu
    Q.-E. Huang
    J.-Y. Jia
    Z.-H. Jia
    L. Wei
    Z.-F. Zheng
    W.-Y. Shang
    Journal of Endocrinological Investigation, 2013, 36 : 938 - 943
  • [49] Metabolomics of the diabetic nephropathy: behind the fingerprint of development and progression indicators
    Cordero-Perez, Paula
    Sanchez-Martinez, Concepcion
    Alberto Garcia-Hernandez, Pedro
    Saucedo, Alma L.
    NEFROLOGIA, 2020, 40 (06): : 585 - 596
  • [50] Time to Prevent the Development of Diabetic Nephropathy
    El Din, Usama A. Sharaf
    Salem, Mona M.
    Abdulazim, Dona O.
    TURKISH JOURNAL OF NEPHROLOGY, 2020, 29 (02): : 161 - 173